Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intratympanic Injection for Autoimmune Inner Ear Disease (AIED)

This study has been terminated.
(House Research no longer conducting research.)
Sponsor:
Collaborator:
Janssen Services, LLC
Information provided by (Responsible Party):
House Research Institute
ClinicalTrials.gov Identifier:
NCT01526174
First received: February 1, 2012
Last updated: October 10, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)